rs6967334

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000722.4(CACNA2D1):​c.95+10913C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.294 in 152,182 control chromosomes in the GnomAD database, including 8,027 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.29 ( 8027 hom., cov: 34)

Consequence

CACNA2D1
NM_000722.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.157

Publications

3 publications found
Variant links:
Genes affected
CACNA2D1 (HGNC:1399): (calcium voltage-gated channel auxiliary subunit alpha2delta 1) The preproprotein encoded by this gene is cleaved into multiple chains that comprise the alpha-2 and delta subunits of the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. Mutations in this gene can cause cardiac deficiencies, including Brugada syndrome and short QT syndrome. Alternate splicing results in multiple transcript variants, some of which may lack the delta subunit portion. [provided by RefSeq, Nov 2014]
CACNA2D1 Gene-Disease associations (from GenCC):
  • short QT syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: ClinGen, Orphanet
  • Brugada syndrome
    Inheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • developmental and epileptic encephalopathy 110
    Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • Brugada syndrome 1
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.532 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000722.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA2D1
NM_000722.4
MANE Select
c.95+10913C>G
intron
N/ANP_000713.2
CACNA2D1
NM_001366867.1
c.95+10913C>G
intron
N/ANP_001353796.1
CACNA2D1
NM_001302890.2
c.95+10913C>G
intron
N/ANP_001289819.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA2D1
ENST00000356860.8
TSL:1 MANE Select
c.95+10913C>G
intron
N/AENSP00000349320.3
CACNA2D1
ENST00000423588.1
TSL:1
c.95+10913C>G
intron
N/AENSP00000405395.1
CACNA2D1
ENST00000443883.2
TSL:5
c.95+10913C>G
intron
N/AENSP00000409374.2

Frequencies

GnomAD3 genomes
AF:
0.294
AC:
44779
AN:
152062
Hom.:
8032
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0923
Gnomad AMI
AF:
0.208
Gnomad AMR
AF:
0.254
Gnomad ASJ
AF:
0.322
Gnomad EAS
AF:
0.401
Gnomad SAS
AF:
0.551
Gnomad FIN
AF:
0.403
Gnomad MID
AF:
0.303
Gnomad NFE
AF:
0.383
Gnomad OTH
AF:
0.310
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.294
AC:
44776
AN:
152182
Hom.:
8027
Cov.:
34
AF XY:
0.298
AC XY:
22212
AN XY:
74412
show subpopulations
African (AFR)
AF:
0.0922
AC:
3831
AN:
41552
American (AMR)
AF:
0.253
AC:
3875
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.322
AC:
1117
AN:
3468
East Asian (EAS)
AF:
0.402
AC:
2073
AN:
5162
South Asian (SAS)
AF:
0.549
AC:
2648
AN:
4820
European-Finnish (FIN)
AF:
0.403
AC:
4266
AN:
10584
Middle Eastern (MID)
AF:
0.295
AC:
86
AN:
292
European-Non Finnish (NFE)
AF:
0.383
AC:
26032
AN:
67978
Other (OTH)
AF:
0.311
AC:
658
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1561
3122
4682
6243
7804
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
472
944
1416
1888
2360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.228
Hom.:
604
Bravo
AF:
0.268
Asia WGS
AF:
0.414
AC:
1442
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
2.6
DANN
Benign
0.50
PhyloP100
0.16
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6967334; hg19: chr7-82061768; API